Minerva Imaging will attend the EANM Congress 2019, October 12 – 16, 2019, Barcelona, Spain.

Minerva Imaging is working with preclinical disease models in oncology, cardiovascular disease and inflammation. We are specialized in nuclear medicine and have a strong track record in targeted radionuclide therapy and translational imaging studies.

If you are interested in learning more about our services or set up a meeting during the congress, please feel free to contact co-founder and CEO, Carsten H. Nielsen or co-founder and CSO, Andreas Kjaer.